Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants
about
Viral quasispecies evolutionTreatment for hepatitis B in patients with drug resistanceClinical utility of complex mutations in the core promoter and proximal precore regions of the hepatitis B virus genomeMutation profiling of the hepatitis B virus strains circulating in North Indian populationRecent advances in micro/nanotechnologies for global control of hepatitis B infectionPrevalent HBV point mutations and mutation combinations at BCP/preC region and their association with liver disease progression.Mutations in pre-core and basal-core promoter regions of hepatitis B virus in chronic HBV patients from Golestan, Iran.Practical approach in hepatitis B e antigen-negative individuals to identify treatment candidates.Hepatitis B virus gene mutations in liver diseases: a report from New Delhi.Impact of the rtI187V polymerase substitution of hepatitis B virus on viral replication and antiviral drug susceptibilityHepatitis B viral DNA decline at loss of HBeAg is mainly explained by reduced cccDNA load--down-regulated transcription of PgRNA has limited impactDifferences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in ColombiaOligonucleotides and polyribonucleotides: a review of antiviral activity.Retrospective study of the prevalence and clinical significance of hepatitis B virus precore and basal core promoter variants.Personal view: the management of chronic hepatitis B infection.Mutations affecting the replication capacity of the hepatitis B virus.Quasispecies structure, cornerstone of hepatitis B virus infection: mass sequencing approach.LUC7L3/CROP inhibits replication of hepatitis B virus via suppressing enhancer II/basal core promoter activity.Atypical serological profiles in hepatitis B virus infection.Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance.Combined Analysis of the Prevalence of Drug-Resistant Hepatitis B Virus in Antiviral Therapy-Experienced Patients in Europe (CAPRE).Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genomeInfluence of the basal core promoter and precore mutation on replication of hepatitis B virus and antiviral susceptibility of different genotypes.Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains.Impact of hepatitis B e antigen-suppressing mutations on the replication efficiency of entecavir-resistant hepatitis B virus strains.Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains.The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen-positive and hepatitis B e antigen-negative hepatitis B virus strains.Lamivudine resistance in patients with chronic hepatitis B: role of clinical and virological factors.Molecular interactions between hepatitis B virus and delta virus.Selection of the highly replicative and partially multidrug resistant rtS78T HBV polymerase mutation during TDF-ETV combination therapy.CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter.A novel hepatitis B virus subgenotype D10 circulating in Ethiopia.Lamivudine resistance of hepatitis B virus masked by coemergence of mutations in probe region of the COBAS AMPLICOR assay.Hepatitis B virus core promoter mutations in patients with chronic hepatitis B and hepatocellular carcinoma in bucharest, romania.Impact of Drug-Resistance Polymerase Mutations on the Replication of HBeAg-Positive and HBeAg-Negative Hepatitis B Virus Strains in Vitro.Novel point mutations and mutational complexes in the enhancer II, core promoter and precore regions of hepatitis B virus genotype D1 associated with hepatocellular carcinoma in Saudi Arabia.Role of hepatitis B virus base core and precore/core promoter mutations on hepatocellular carcinoma in untreated older genotype C Chinese patients.Single-step real-time PCR to quantify hepatitis B virus and distinguish genotype D from non-D genotypes.Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.
P2860
Q27013917-0EE74BDA-F487-4776-A106-309D615B4A0CQ28072483-19C94E15-C38D-4384-AC21-4B56E11C0224Q28080587-B729DD1D-B527-4DED-8155-5B1F20612B42Q28540948-70D6F84B-CD45-48F2-A86E-3C07BA3A0532Q30394611-FB38A1C5-00D7-4B9E-A770-AE9C21842B60Q33693941-E59759FB-746E-458C-AED0-94534BC954FFQ33802585-3698DAD6-D2B8-4FD4-9002-362970722A40Q34168465-77DDB8C5-7131-4D4D-A151-4EFEAC2B1C33Q34312096-10FE09D3-98A6-4C01-98B7-7FB62BD0D3F2Q34366437-8E064AB0-3B01-4A6C-BD35-E82C2070E37EQ34387363-D2182E6D-FA29-45E1-A35F-CF6405B6DBC9Q34700034-E52AE175-0399-4ADA-A360-3D8A17628FE4Q35224439-BF787C9A-30CB-4569-8DE8-1857AA6B1375Q36124734-D347C5AE-A91C-4E54-BD40-EE9AA852B0D2Q36425714-75D748CF-C5EA-4BEE-809B-3C77595783D3Q36435893-7BDDB9FB-5BCD-4C9D-8204-129881FBB7A2Q36515349-CF9AC0B0-E8E3-42D1-8A8E-EE8918DF47B6Q37285249-08D0EC17-4889-4FFB-92F2-4C3DE146BB6AQ37421909-B54CB3F2-BC0A-49E4-930A-191667EC6BAFQ38063427-9A736950-9783-4E79-ADF2-3F36FC43C9BBQ38408847-56AF719B-1F7E-42A7-A9DB-AB033C86D29BQ38424625-2DC531EB-FAE6-4536-B71D-4FD55A71223BQ38830111-E5501474-8E01-4DEC-A376-427262A47097Q38917530-6617D775-6B6D-4B78-A0E1-3FB8F1041C42Q39213627-4A247F16-07DA-4CFC-A078-90DFDBF1BF9EQ39649139-C4E34CAE-FA49-44E5-BD8F-09A627A15FCBQ39778916-376C3DB8-D845-44D0-878C-4F09466DB068Q39876916-9CB23FA7-2465-4843-8B45-8A875F445839Q40197893-2E51D251-5EF4-4C1A-BE45-12ECF84EE4F3Q40245846-9270AFFA-595B-4113-B331-D0B5F54D8F29Q40251459-A17590FA-C8D6-4ED0-A5D3-39AD63839018Q40426622-5D4C83F9-1992-42FD-9FB5-91993B9C7873Q40467978-9E9AD58B-6FB0-431E-87C8-466D1AC5C7E3Q41481346-1BE441B2-6D11-4FAE-9BD9-CDF254D2E436Q41615602-F8A08693-383A-4823-AC58-1605A687A052Q42263110-7A8BF686-B631-4466-810C-E67AE3E0CE1BQ42439574-85460A22-66D6-45EA-A731-D5359FADDA60Q42494265-075B044D-FC20-4709-A2F9-6C2A5E010B8DQ43934269-64E883BC-9681-464D-BD3D-2433A87B80CDQ45375655-25304241-C760-4416-8DE1-35B12D9D9C97
P2860
Basal core promoter and precore mutations in the hepatitis B virus genome enhance replication efficacy of Lamivudine-resistant mutants
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Basal core promoter and precor ...... f Lamivudine-resistant mutants
@ast
Basal core promoter and precor ...... f Lamivudine-resistant mutants
@en
Basal core promoter and precor ...... f Lamivudine-resistant mutants
@nl
type
label
Basal core promoter and precor ...... f Lamivudine-resistant mutants
@ast
Basal core promoter and precor ...... f Lamivudine-resistant mutants
@en
Basal core promoter and precor ...... f Lamivudine-resistant mutants
@nl
prefLabel
Basal core promoter and precor ...... f Lamivudine-resistant mutants
@ast
Basal core promoter and precor ...... f Lamivudine-resistant mutants
@en
Basal core promoter and precor ...... f Lamivudine-resistant mutants
@nl
P2093
P2860
P1433
P1476
Basal core promoter and precor ...... f Lamivudine-resistant mutants
@en
P2093
Christian Trautwein
Christina Gehrke
Frank Tacke
Michael P Manns
Tom Luedde
P2860
P304
P356
10.1128/JVI.78.16.8524-8535.2004
P407
P50
P577
2004-08-01T00:00:00Z